US FDA's New Drug Assessors More Experienced With Rare Disease Issues

 
• By Derrick Gingery
FDA words adn building icon
The FDA's Office of New Drugs reorganization, which includes creation of a new Office of Rare Diseases, Pediatrics and Women's Health, also remains on track. • Source: Shutterstock

More from Approval Standards

More from Pathways & Standards